Profile data is unavailable for this security.
About the company
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
- Revenue in SEK (TTM)1.79bn
- Net income in SEK227.90m
- Incorporated2001
- Employees534.00
- LocationMedCap AB (publ)Engelbrektsgatan 9-1STOCKHOLM 114 32SwedenSWE
- Phone+46 8347110
- Websitehttps://www.medcap.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Linc AB | 1.57bn | 1.58bn | 4.59bn | 2.00 | 2.90 | 0.9929 | -- | 2.92 | 27.30 | 27.30 | 27.12 | 79.77 | 0.4099 | -- | 78.95 | 785,230,500.00 | 41.26 | 9.76 | 41.29 | 9.76 | -- | -- | 100.68 | 98.02 | -- | -- | 0.00 | -- | 173.91 | 16.70 | 185.64 | 14.42 | -- | -- |
| Investment Oresund AB | 920.77m | 937.24m | 5.18bn | 6.00 | 5.53 | 1.08 | -- | 5.63 | 20.62 | 20.62 | 20.26 | 105.90 | 0.1959 | -- | -- | 153,461,800.00 | 19.94 | 0.4157 | 20.76 | 0.4202 | -- | -- | 101.78 | 52.79 | -- | -- | 0.0066 | 1,224.91 | 115.74 | -13.99 | 114.71 | -12.98 | 31.06 | 4.94 |
| Treasure ASA | -207.47m | 374.80m | 5.71bn | 0.00 | 15.11 | 0.7952 | -- | -- | 1.89 | 1.89 | -1.04 | 35.98 | -0.0298 | -- | -- | -- | 5.38 | 10.76 | 5.38 | 10.76 | -- | -- | -- | 887.92 | -- | -- | 0.00 | 262.19 | -- | -- | -15.28 | -- | -- | 26.72 |
| Svolder AB | 895.30m | 876.20m | 6.27bn | 6.00 | 6.88 | 1.02 | -- | 7.01 | 8.68 | 8.68 | 8.73 | 58.80 | 0.1585 | -- | 157.07 | 149,216,700.00 | 15.51 | 12.58 | 15.55 | 12.63 | 96.93 | 97.87 | 97.87 | 96.09 | -- | -- | 0.00 | 14.64 | 283.16 | 138.51 | 266.74 | -- | 0.00 | 25.90 |
| eQ Oyj | 819.38m | 346.19m | 6.38bn | 104.00 | 18.32 | 8.07 | 17.72 | 7.78 | 0.7206 | 0.7206 | 1.71 | 1.64 | 0.7207 | -- | 119.17 | 695,524.80 | 30.45 | 31.07 | 34.33 | 37.81 | 98.82 | 99.25 | 42.25 | 44.88 | -- | -- | 0.0587 | 102.65 | -8.67 | 9.36 | -13.21 | 12.11 | -25.33 | 8.18 |
| Creades publ AB | 2.17bn | 2.10bn | 6.69bn | 8.00 | 4.64 | 0.9881 | -- | 3.08 | 15.49 | 15.49 | 16.01 | 72.72 | 0.2396 | -- | 149.86 | 310,428,600.00 | 23.19 | 13.15 | 23.54 | 13.38 | -- | -- | 96.78 | 93.42 | -- | -- | 0.0011 | 12.58 | 112.11 | -16.86 | 114.13 | 1.03 | -- | 2.71 |
| MedCap AB (publ) | 1.79bn | 227.90m | 8.50bn | 534.00 | 37.57 | 7.12 | 24.98 | 4.75 | 15.28 | 15.28 | 119.92 | 80.58 | 1.02 | 3.58 | 6.30 | 3,758,614.00 | 13.10 | 9.01 | 16.16 | 12.00 | 46.63 | 46.77 | 12.80 | 9.84 | 1.83 | 43.34 | 0.2248 | 0.00 | 42.84 | 17.49 | 46.43 | 47.82 | 2.82 | -- |
| Ratos AB | 32.35bn | 958.00m | 11.08bn | 11.05k | 11.67 | 0.9013 | 2.59 | 0.3424 | 2.89 | 2.89 | 98.46 | 37.37 | 0.9202 | 9.24 | 5.90 | 2,926,814.00 | 5.08 | 3.39 | 7.58 | 5.11 | 43.26 | 40.22 | 5.52 | 4.06 | 0.7346 | 1.32 | 0.3988 | 44.71 | 12.96 | 7.85 | 122.26 | -- | -15.01 | 20.11 |
| Holder | Shares | % Held |
|---|---|---|
| Lannebo Fonder ABas of 31 Aug 2024 | 1.27m | 8.59% |
| Spiltan Fonder ABas of 31 Dec 2023 | 1.27m | 8.59% |
| Swedbank Robur Fonder ABas of 24 Jul 2024 | 796.79k | 5.38% |
| Alcur Fonder ABas of 31 Dec 2023 | 567.62k | 3.83% |
| Nordea Investment Management ABas of 30 Jun 2024 | 549.78k | 3.71% |
| ODIN Forvaltning AS (Sweden)as of 31 Dec 2023 | 500.00k | 3.38% |
| Andra AP-fondenas of 31 Dec 2023 | 476.77k | 3.22% |
| Handelsbanken Fonder ABas of 30 Sep 2024 | 339.42k | 2.29% |
| Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 29 Sep 2023 | 267.59k | 1.81% |
| L�nsf�rs�kringar Fondf�rvaltning ABas of 30 Sep 2024 | 256.50k | 1.73% |
